Oliclinomel N4-550e

Glycine, the active ingredient in Oliclinomel N4-550e, is a parenteral nutrition supplement presented as an intravenous solution for intravenous use. It supports patients requiring parenteral nutrition support, particularly in clinical settings such as intensive care or postoperative recovery.

GNH USA supplies Oliclinomel N4-550e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oliclinomel N4-550e is used in clinical nutrition to provide essential nutrients for patients who cannot receive enteral feeding. - Post‑operative patients: helps maintain caloric and protein needs during recovery. - Critical‑care patients: supplies necessary amino acids and electrolytes when oral intake is not possible. - Long‑term parenteral nutrition: sustains nutritional status for patients with chronic gastrointestinal failure.

Adverse reactions may occur with any intravenous nutrition product and should be monitored during therapy.

Common Side Effects: - Phlebitis at the infusion site: inflammation of the vein. - Mild hypertriglyceridemia: slight increase in blood triglyceride levels. - Transient electrolyte imbalance: temporary changes in potassium or magnesium levels. - Fever or chills: mild temperature elevation during infusion. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of hives, airway swelling, or hypotension. - Acute liver dysfunction: marked elevation of liver enzymes. - Hyperosmolar hyperglycaemic state: high blood glucose in susceptible patients. - Pulmonary embolism: rare clot formation linked to lipid emulsions. - Sepsis seeding: infection risk from contaminated infusion sets.

When using Oliclinomel N4-550e, clinicians should assess patient suitability and monitor therapy closely. - Assess renal function: adjust electrolyte content if renal impairment is present. - Monitor electrolytes: regular checks of potassium and magnesium levels are recommended. - Observe infusion site: watch for signs of phlebitis or infiltration. - Evaluate liver function: periodic liver enzyme testing may be needed. - Review lipid tolerance: consider triglyceride levels in patients with hyperlipidaemia. - Store at 2-8°C: keep refrigerated, protect from light ; avoid freezing and shake before use.

Oliclinomel N4-550e may interact with other intravenous therapies and medications that affect electrolyte balance.

Major Interactions (Avoid): - Concurrent high‑dose potassium chloride: risk of hyper‑kalemia. - Magnesium‑containing infusions or supplements : increased risk of hyper‑magnesium. - Lipid‑based parenteral nutrients : potential overload of caloric intake.\nModerate Interaction M ":[ { "@type": "Drug", "name": "Oliclinomel N4-550e", "description": "Parenteral nutrition supplement", "activeIngredient": [ "Glycine", "Olive Oil, Refined", "Soya-Bean Oil Refined", "Magnesium Chloride Hexahydrate", "Potassium Chloride", "Water", "Sodium Chloride", "Buffer "); "manufacturer": "GNH "); } ]